Lundbeck

Health

AdminNovember 12, 2024
0 5

“Less than 3.5% of migraine patients who would benefit from monoclonal antibody treatment seek it.”
Health

AdminJune 23, 2024
0 136

Brexpiprazole, a new oral antipsychotic that improves positive, negative, and affective symptoms of schizophrenia.